Estradiol attenuates the cognitive deficits in the novel object recognition task induced by sub-chronic phencyclidine in ovariectomized rats

Behavioural Brain Research

Volumn 233, Issue 1, 2012, Pages 105-112

  Roseman, Alexander S ^a   McGregor, Claire ^a   Thornton, Janice E ^a  

^a OBERLIN COLLEGE   (United States)

Author keywords

Cognitive deficits; Estradiol; Novel object recognition; Phencyclidine; Rat; Schizophrenia

Indexed keywords

ESTRADIOL; PHENCYCLIDINE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; EXPLORATORY BEHAVIOR; FEMALE; HABITUATION; LOCOMOTION; NONHUMAN; OBJECT RECOGNITION TASK; OVARIECTOMY; PRIORITY JOURNAL; RAT; RECOGNITION; SCHIZOPHRENIA; TASK PERFORMANCE; WORKING MEMORY;

ANALYSIS OF VARIANCE; ANIMALS; COGNITION DISORDERS; DISEASE MODELS, ANIMAL; ESTRADIOL; ESTROGENS; EXPLORATORY BEHAVIOR; FEMALE; HALLUCINOGENS; MOTOR ACTIVITY; NEUROPSYCHOLOGICAL TESTS; OVARIECTOMY; PHENCYCLIDINE; RATS; RATS, SPRAGUE-DAWLEY; RECOGNITION (PSYCHOLOGY); STATISTICS, NONPARAMETRIC; TIME FACTORS;

EID: 84861555188     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2012.04.037     Document Type: Article

References (61)

1. Green M.F. What are the functional consequences of neurocognitive deficits in schizophrenia?. American Journal of Psychiatry 1996, 153:321-330.
2. Green M.F. Cognitive impairment and functional outcome in schizophrenia and bipolar disorder. Journal of Clinical Psychiatry 2006, 67:e12.
3. Kulkarni J., de Castella A., Smith D., Taffe J., Keks N., Copolov D. A clinical trial of the effects of estrogen in acutely psychotic women. Schizophrenia Research 1996, 20:247-252.
4. Kulkarni J., Riedel A., Rd Castella A., Fitzgerald P.B., Rolfe T.J., Taffe J., et al. Estrogen - a potential treatment for schizophrenia. Schizophrenia Research 2001, 48:137-144.
5. Kulkarni J., Gurvich C., Gilbert H., Mehmedbegovic F., Mu L., Marston N., et al. Hormone modulation: a novel therapeutic approach for women with severe mental illness. Australian and New Zealand Journal of Psychiatry 2008, 42:83-88.
6. Lindamer L.A., Buse D.C., Lohr J.B., Jeste D.V. Hormone replacement therapy in postmenopausal women with schizophrenia: positive effect on negative symptoms?. Biological Psychiatry 2001, 49:47-51.
7. Krystal J.H., Karper L.P., Seibyl J.P., Freeman G.K., Delaney R., Bremner J.D., et al. Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. Archives of General Psychiatry 1994, 51:199-214.
8. Malhotra A.K., Pinals D.A., Weingartner H., Sirocco K., Missar C.D., Pickar D., et al. NMDA receptor function and human cognition: the effects of ketamine in healthy volunteers. Neuropsychopharmacology 1996, 14:301-307.
9. Malhotra A.K., Pinals D.A., Adler C.M., Elman I., Clifton A., Pickar D., et al. Ketamine-induced exacerbation of psychotic symptoms and cognitive impairment in neuroleptic-free schizophrenics. Neuropsychopharmacology 1997, 17:141-150.
10. Jentsch J.D., Redmond D.E., Elsworth J.D., Taylor J.R., Youngren K.D., Roth R.H. Enduring cognitive deficits and cortical dopamine dysfunction in monkeys after long-term administration of phencyclidine. Science 1997, 277:953-955.
11. Jentsch J.D., Taylor J.R., Roth R.H. Subchronic phencyclidine administration increases mesolimbic dopaminergic system responsivity and augments stress- and psychostimulant-induced hyperlocomotion. Neuropsychopharmacology 1998, 19:105-113.
12. Snigdha S., Neill J.C. Efficacy of antipsychotics to reverse phencyclidine-induced social interaction deficits in female rats--a preliminary investigation. Behavioural Brain Research 2008, 187:489-494.
13. Marcotte E.R., Pearson D.M., Srivastava L.K. Animal models of schizophrenia: a critical review. Journal of Psychiatry and Neuroscience 2001, 26:395-410.
14. Jentsch J.D., Taylor J.R., Roth R.H. Subchronic phencyclidine administration increases mesolimbic dopaminergic system responsivity and augments stress- and psychostimulant-induced hyperlocomotion. Neuropsychopharmacology 1998, 19:105-113. 10.1016/S0893-133X(98)00004-9.
15. Mouri A., Noda Y., Enomoto T., Nabeshima T. Phencyclidine animal models of schizophrenia: approaches from abnormality of glutamatergic neurotransmission and neurodevelopment. Neurochemistry International 2007, 51:173-184.
16. Abdul-Monim Z., Neill J.C., Reynolds G.P. Sub-chronic psychotomimetic phencyclidine induces deficits in reversal learning and alterations in parvalbumin-immunoreactive expression in the rat. Journal of Psychopharmacology 2007, 21:198-205.
17. Grayson B., Idris N.F., Neill J.C. Atypical antipsychotics attenuate a sub-chronic PCP-induced cognitive deficit in the novel object recognition task in the rat. Behavioural Brain Research 2007, 184:31-38.
18. Reynolds L.M., Cochran S.M., Morris B.J., Pratt J.A., Reynolds G.P. Chronic phencyclidine administration induces schizophrenia-like changes in N-acetylaspartate and N-acetylaspartylglutamate in rat brain. Schizophrenia Research 2005, 73:147-152. 10.1016/j.schres.2004.02.003.
19. Tsai G., Passani L.A., Slusher B.S., Carter R., Baer L., Kleinman J.E., et al. Abnormal excitatory neurotransmitter metabolism in schizophrenic brains. Archives of General Psychiatry 1995, 52:829-836.
20. Zhang Z.J., Reynolds G.P. A selective decrease in the relative density of parvalbumin-immunoreactive neurons in the hippocampus in schizophrenia. Schizophrenia Research 2002, 55:1-10.
21. Benneyworth M.A., Roseman A.S., Basu A.C., Coyle J.T. Failure of NMDA receptor hypofunction to induce a pathological reduction in PV-positive GABAergic cell markers. Neuroscience Letters 2011, 488:267-271.
22. Dere E., Huston J.P., De Souza Silva M.A. The pharmacology, neuroanatomy and neurogenetics of one-trial object recognition in rodents. Neuroscience and Biobehavioral Reviews 2007, 31:673-704. 10.1016/j.neubiorev.2007.01.005.
23. Sutcliffe J.S., Rhaman F., Marshall K., Neill J.C. Oestradiol attenuates the cognitive deficit induced by acute phencyclidine treatment in mature female hooded-Lister rats. Journal of Psychopharmacology 2008, 22:918-922.
24. Berry A., Tomidokoro Y., Ghiso J., Thornton J. Human chorionic gonadotropin (a luteinizing hormone homologue) decreases spatial memory and increases brain amyloid-beta levels in female rats. Hormones and Behavior 2008, 54:143-152.
25. Legan S.J., Coon G.A., Karsch F.J. Role of estrogen as initiator of daily LH surges in the ovariectomized rat. Endocrinology 1975, 96:50-56.
26. Karsch F.J., Dierschke D.K., Weick R.F., Yamaji T., Hotchkiss J., Knobil E. Positive and negative feedback control by estrogen of luteinizing hormone secretion in the rhesus monkey. Endocrinology 1973, 92:799-804.
27. Jones H.E., Waynforth H.B., Pope G.S. The effect of miroestrol on vaginal cornification, pituitary function and pregnancy in the rat. Journal of Endocrinology 1961, 22:293-302.
28. Ennaceur A., Delacour J. A new one-trial test for neurobiological studies of memory in rats. 1: behavioral data. Behavioural Brain Research 1988, 31:47-59.
29. Snigdha S., Horiguchi M., Li Z., Huang M., Shahid M., Neill J., et al. Attenuation of phencyclidine-induced object recognition deficits by the combination of atypical antipsychotic drugs with pimavanserin (ACP 103), a 5-hydroxytryptamine2A receptor inverse agonist. Journal of Pharmacology and Experimental Therapeutics 2009, 10.1124/jpet.109.156349.
30. Hashimoto K., Fujita Y., Shimizu E., Iyo M. Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of clozapine, but not haloperidol. European Journal of Pharmacology 2005, 519:114-117.
31. Jentsch J.D., Roth R.H. The neuropsychopharmacology of phencyclidine: from NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia. Neuropsychopharmacology 1999, 20:201-225.
32. Luine V.N., Jacome L.F., Maclusky N.J. Rapid enhancement of visual and place memory by estrogens in rats. Endocrinology 2003, 144:2836-2844.
33. Fernandez S.M., Frick K.M. Chronic oral estrogen affects memory and neurochemistry in middle-aged female mice. Behavioral Neuroscience 2004, 118:1340-1351.
34. Vaucher E., Reymond I., Najaffe R., Kar S., Quirion R., Miller M.M., et al. Estrogen effects on object memory and cholinergic receptors in young and old female mice. Neurobiology of Aging 2002, 23:87-95.
35. Sturgeon R.D., Fessler R.G., London S.F., Meltzer H.Y. Behavioral effects of chronic phencyclidine administration in rats. Psychopharmacology (Berlin) 1982, 76:52-56.
36. Nabeshima T., Fukaya H., Yamaguchi K., Ishikawa K., Furukawa H., Kameyama T. Development of tolerance and supersensitivity to phencyclidine in rats after repeated administration of phencyclidine. European Journal of Pharmacology 1987, 135:23-33.
37. Ennaceur A. One-trial object recognition in rats and mice: methodological and theoretical issues. Behavioural Brain Research 2010, 215:244-254.
38. Angermeyer M.C., Kuhn L. Gender differences in age at onset of schizophrenia. An overview. European Archives of Psychiatry and Neurological Sciences 1988, 237:351-364.
39. Cohen R.Z., Seeman M.V., Gotowiec A., Kopala L. Earlier puberty as a predictor of later onset of schizophrenia in women. American Journal of Psychiatry 1999, 156:1059-1064.
40. Seeman M.V. The role of estrogen in schizophrenia. Journal of Psychiatry and Neuroscience 1996, 21:123-127.
41. Bergemann N., Parzer P., Runnebaum B., Resch F., Mundt C. Estrogen, menstrual cycle phases, and psychopathology in women suffering from schizophrenia. Psychological Medicine 2007, 37:1427-1436.
42. Seeman M.V. Interaction of sex, age, and neuroleptic dose. Comprehensive Psychiatry 1983, 24:125-128.
43. Bergemann N., Mundt C., Parzer P., Jannakos I., Nagl I., Salbach B., et al. Plasma concentrations of estradiol in women suffering from schizophrenia treated with conventional versus atypical antipsychotics. Schizophrenia Research 2005, 73:357-366.
44. Callaghan J.T., Bergstrom R.F., Ptak L.R., Olanzapine Beasley C.M. Pharmacokinetic and pharmacodynamic profile. Clinical Pharmacokinetics 1999, 37:177-193.
45. Lane H.Y., Chang Y.C., Chang W.H., Lin S.K., Tseng Y.T., Jann M.W. Effects of gender and age on plasma levels of clozapine and its metabolites: analyzed by critical statistics. Journal of Clinical Psychiatry 1999, 60:36-40.
46. Sutcliffe J.S., Marshall K.M., Neill J.C. Influence of gender on working and spatial memory in the novel object recognition task in the rat. Behavioural Brain Research 2007, 177:117-125.
47. Wallace M., Luine V., Arellanos A., Frankfurt M. Ovariectomized rats show decreased recognition memory and spine density in the hippocampus and prefrontal cortex. Brain Research 2006, 1126:176-182.
48. Frye C.A., Duffy C.K., Walf A.A. Estrogens and progestins enhance spatial learning of intact and ovariectomized rats in the object placement task. Neurobiology of Learning and Memory 2007, 88:208-216.
49. Walf A.A., Rhodes M.E., Frye C.A. Ovarian steroids enhance object recognition in naturally cycling and ovariectomized, hormone-primed rats. Neurobiology of Learning and Memory 2006, 86:35-46.
50. Corso T.D., Sesma M.A., Tenkova T.I., Der T.C., Wozniak D.F., Farber N.B., et al. Multifocal brain damage induced by phencyclidine is augmented by pilocarpine. Brain Research 1997, 752:1-14.
51. Tang Y., Janssen W.G., Hao J., Roberts J.A., McKay H., Lasley B., et al. Estrogen replacement increases spinophilin-immunoreactive spine number in the prefrontal cortex of female rhesus monkeys. Cerebral Cortex 2004, 14:215-223.
52. Bimonte-Nelson H.A., Acosta J.I., Talboom J.S. Neuroscientists as cartographers: mapping the crossroads of gonadal hormones, memory and age using animal models. Molecules 2010, 15:6050-6105.
53. Dohanich G., Korol D., Shors T. Steroids, learning and memory. Hormones, Brain, and Behavior 2009, 539-576. Academic Press, San Diego {CA}. 2nd ed. D. Pfaff, A.P. Arnold, A.M. Etgen, S.E. Fahrbach, R.T. Rubin (Eds.).
54. Gibbs R.B. Estrogen therapy and cognition: a review of the cholinergic hypothesis. Endocrine Reviews 2010, 31:224-253.
55. Lewis M.C., Kerr K.M., Orr P.T., Frick K.M. Estradiol-induced enhancement of object memory consolidation involves NMDA receptors and protein kinase A in the dorsal hippocampus of female C57BL/6 mice. Behavioral Neuroscience 2008, 122:716-721.
56. Gould E., Woolley C.S., Frankfurt M., McEwen B.S. Gonadal steroids regulate dendritic spine density in hippocampal pyramidal cells in adulthood. Journal of Neuroscience 1990, 10:1286-1295.
57. Woolley C.S., Gould E., Frankfurt M., McEwen B.S. Naturally occurring fluctuation in dendritic spine density on adult hippocampal pyramidal neurons. Journal of Neuroscience 1990, 10:4035-4039.
58. Li C., Brake W.G., Romeo R.D., Dunlop J.C., Gordon M., Buzescu R., et al. Estrogen alters hippocampal dendritic spine shape and enhances synaptic protein immunoreactivity and spatial memory in female mice. Proceedings of the National Academy of Sciences of the United States of America 2004, 101:2185-2190.
59. Gibbs R.B. Levels of trkA and BDNF mRNA, but not NGF mRNA, fluctuate across the estrous cycle and increase in response to acute hormone replacement. Brain Research 1998, 787:259-268.
60. Tanapat P., Hastings N.B., Reeves A.J., Gould E. Estrogen stimulates a transient increase in the number of new neurons in the dentate gyrus of the adult female rat. Journal of Neuroscience 1999, 19:5792-5801.
61. McCarthy M.M., Becker J.B. Neuoendocrinology of sexual behavior in the female. Behavioral Endocrinology 2002, 117-151. MIT Press. J.B. Becker, S.M. Breedlove, D. Crews, M.M. McCarthy (Eds.).